TRCT
TELA icon

Tower Research Capital (TRC)’s TELA Bio TELA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Buy
13,612
+12,728
+1,440% +$10.4K ﹤0.01% 3991
2026
Q1 		$548 Buy
+884
New +$768 ﹤0.01% 4842
2025
Q1 		– Sell
-923
Closed -$2.79K – 5777
2024
Q4 		$2.79K Sell
923
-794
-46% -$2.23K ﹤0.01% 4773
2024
Q3 		$4.34K Sell
1,717
-6,000
-78% -$21.3K ﹤0.01% 4578
2024
Q2 		$36.3K Buy
7,717
+5,981
+345% +$31.5K ﹤0.01% 3345
2024
Q1 		$9.84K Sell
1,736
-43
-2% -$284 ﹤0.01% 3782
2023
Q4 		$11.8K Sell
1,779
-398
-18% -$2.3K ﹤0.01% 4101
2023
Q3 		$17.4K Buy
2,177
+1,822
+513% +$16.9K ﹤0.01% 3503
2023
Q2 		$3.6K Sell
355
-143
-29% -$1.46K ﹤0.01% 5045
2023
Q1 		$5K Sell
498
-854
-63% -$9.42K ﹤0.01% 4993
2022
Q4 		$16K Sell
1,352
-2,010
-60% -$18K ﹤0.01% 3374
2022
Q3 		$29K Sell
3,362
-7,159
-68% -$59.4K ﹤0.01% 3639
2022
Q2 		$74K Buy
10,521
+9,331
+784% +$77.5K ﹤0.01% 2528
2022
Q1 		$14K Buy
1,190
+677
+132% +$8.2K ﹤0.01% 3925
2021
Q4 		$7K Buy
+513
New +$6.5K ﹤0.01% 4948
2021
Q3 		– Sell
-1,083
Closed -$17K – 6165
2021
Q2 		$17K Buy
1,083
+530
+96% +$7.26K ﹤0.01% 4052
2021
Q1 		$8K Sell
553
-827
-60% -$12.5K ﹤0.01% 4486
2020
Q4 		$21K Sell
1,380
-3,830
-74% -$62.2K ﹤0.01% 3848
2020
Q3 		$86K Buy
5,210
+3,810
+272% +$53.5K ﹤0.01% 3259
2020
Q2 		$18K Sell
1,400
-1,568
-53% -$20.6K ﹤0.01% 3742
2020
Q1 		$23K Buy
+2,968
New +$40.1K ﹤0.01% 1647

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $448M AUM 50.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tower Research Capital (TRC)'s TELA Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its TELA Bio (TELA) stake by 1,440% in Q2 2026, buying an estimated $10.4K and bringing the position to 13,612 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3991.

Tower Research Capital (TRC) first reported a position in TELA in Q1 2020 and has held it in 21 quarters since. The position peaked at $86K in Q3 2020. 45 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Tower Research Capital (TRC) held 13,612 shares of TELA Bio worth $10.2K as of Q2 2026.
  • Tower Research Capital (TRC) bought 12,728 TELA Bio shares in Q2 2026, an estimated $10.4K.
  • TELA Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3991 holding.
  • Tower Research Capital (TRC) first reported a position in TELA Bio in Q1 2020 and has held it in 21 quarters since.
  • Tower Research Capital (TRC)'s TELA Bio position peaked at $86K in Q3 2020.
  • 45 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.